Read more
12:55 PM · 22 July 2024

Top stock reports to watch this week (22.07.2024)

A new week has begun, and it is the week many Wall Street investors have been waiting for. Traders will be offered first reports from US Big Tech companies in the coming days. This week's highlight is Tuesday, when Alphabet and Tesla report their Q2 financials after the close of the US stock market session. However, there will also be a number of other well-known companies reporting results this week, including 7 members of the Dow Jones index.

Dow Jones members reporting this week

  • 3M (MMM.US)
  • Coca-Cola (KO.US)
  • Dow Inc (DOW.US)
  • Honeywell International (HON.US)
  • IBM (IBM.US)
  • Visa (V.US)
  • Verizon Communications (VZ.US)

Top Wall Street earnings report scheduled for this week. Source: xStation5

24 April 2026, 6:40 PM

US Open: Nasdaq surges as semiconductor stocks improve sentiments on Wall Street

24 April 2026, 5:49 PM

🚩Avid Budget meme stock sinks as panic ended the 600% surge

24 April 2026, 4:45 PM

Market Wrap: Indices try to recover on US-Iran negotiations hopes 🇪🇺 SAP surges 6% after earnings 📈

24 April 2026, 1:13 PM

Intel: AI drives results, and CPUs may be the next stage of the revolution

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.